Safely increasing the proportion of patients with community-acquired pneumonia treated as outpatients: an interventional trial - PubMed (original) (raw)
Safely increasing the proportion of patients with community-acquired pneumonia treated as outpatients: an interventional trial
S J Atlas et al. Arch Intern Med. 1998.
Abstract
Background: Patients with community-acquired pneumonia who are at low risk for short-term mortality can be identified using a validated prediction rule, the Pneumonia Severity Index. Such patients should be candidates for outpatient treatment, yet many are hospitalized.
Objective: To assess a program to safely increase the proportion of low-risk patients with pneumonia treated at home.
Methods: The intervention provided physicians with the Pneumonia Severity Index score and corresponding mortality risk for eligible patients and offered enhanced visiting nurse services and the antibiotic clarithromycin. Prospectively enrolled, consecutive low-risk patients with pneumonia presenting to an emergency department during the intervention period (n = 166) were compared with consecutive retrospective controls (n = 147) identified during the prior year. A second group of 208 patients from the study hospital who participated in the Pneumonia Patient Outcomes Research Team cohort study served as controls for patient-reported measures of recovery.
Results: There were no significant baseline differences between patients in the intervention and control groups. The percentage initially treated as outpatients increased from 42% in the control period to 57% in the intervention period (36% relative increase; 95% confidence interval, 8%-72%; P = .01). However, more outpatients during the intervention period were subsequently admitted to the study hospital (9% vs 0%). When any admission to the study hospital within 4 weeks of presentation was considered, there was a trend toward more patients receiving all their care as outpatients in the intervention group (42% vs 52%; 25% relative increase; 95% confidence interval -2% to 59%; P = .07). No patient in the intervention group died in the 4-week follow-up period. Symptom resolution and functional status were not diminished. Satisfaction with overall care was similar, but patients treated in the outpatient setting during the intervention were less frequently satisfied with the initial treatment location than comparable control patients (71% vs 90%; P = .04).
Conclusions: Use of a risk-based algorithm coupled with enhanced outpatient services effectively identified low-risk patients with community-acquired pneumonia in the emergency department and safely increased the proportion initially treated as outpatients. Outpatients in the intervention group were more likely to be subsequently admitted than were controls, lessening the net impact of the intervention.
Similar articles
- The hospital admission decision for patients with community-acquired pneumonia. Results from the pneumonia Patient Outcomes Research Team cohort study.
Fine MJ, Hough LJ, Medsger AR, Li YH, Ricci EM, Singer DE, Marrie TJ, Coley CM, Walsh MB, Karpf M, Lahive KC, Kapoor WN. Fine MJ, et al. Arch Intern Med. 1997 Jan 13;157(1):36-44. Arch Intern Med. 1997. PMID: 8996039 - Preferences for home vs hospital care among low-risk patients with community-acquired pneumonia.
Coley CM, Li YH, Medsger AR, Marrie TJ, Fine MJ, Kapoor WN, Lave JR, Detsky AS, Weinstein MC, Singer DE. Coley CM, et al. Arch Intern Med. 1996 Jul 22;156(14):1565-71. Arch Intern Med. 1996. PMID: 8687265 - Outpatient care compared with hospitalization for community-acquired pneumonia: a randomized trial in low-risk patients.
Carratalà J, Fernández-Sabé N, Ortega L, Castellsagué X, Rosón B, Dorca J, Fernández-Agüera A, Verdaguer R, Martínez J, Manresa F, Gudiol F. Carratalà J, et al. Ann Intern Med. 2005 Feb 1;142(3):165-72. doi: 10.7326/0003-4819-142-3-200502010-00006. Ann Intern Med. 2005. PMID: 15684204 Clinical Trial. - Community-acquired pneumonia requiring hospitalisation. Factors of importance for the short-and long term prognosis.
Hedlund J. Hedlund J. Scand J Infect Dis Suppl. 1995;97:1-60. Scand J Infect Dis Suppl. 1995. PMID: 8584866 Review. - How should we make the admission decision in community-acquired pneumonia?
Aronsky D, Dean NC. Aronsky D, et al. Med Clin North Am. 2001 Nov;85(6):1397-411. doi: 10.1016/s0025-7125(05)70387-4. Med Clin North Am. 2001. PMID: 11680109 Review.
Cited by
- Optimal pharmacological therapy for community-acquired pneumonia: the role of dual antibacterial therapy.
Epstein BJ, Gums JG. Epstein BJ, et al. Drugs. 2005;65(14):1949-71. doi: 10.2165/00003495-200565140-00004. Drugs. 2005. PMID: 16162020 Review. - Community-Acquired Pneumonia: An Overview.
Kanno MB, Brown PD. Kanno MB, et al. Curr Infect Dis Rep. 1999 Apr;1(1):49-56. doi: 10.1007/s11908-999-0010-x. Curr Infect Dis Rep. 1999. PMID: 11095767 - Hospital admission decision for patients with community-acquired pneumonia: variability among physicians in an emergency department.
Dean NC, Jones JP, Aronsky D, Brown S, Vines CG, Jones BE, Allen T. Dean NC, et al. Ann Emerg Med. 2012 Jan;59(1):35-41. doi: 10.1016/j.annemergmed.2011.07.032. Epub 2011 Sep 9. Ann Emerg Med. 2012. PMID: 21907451 Free PMC article. - Hospital admission decision for patients with community-acquired pneumonia.
Aliberti S, Faverio P, Blasi F. Aliberti S, et al. Curr Infect Dis Rep. 2013 Apr;15(2):167-76. doi: 10.1007/s11908-013-0323-7. Curr Infect Dis Rep. 2013. PMID: 23378125 - Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults.
Mandell LA, Wunderink RG, Anzueto A, Bartlett JG, Campbell GD, Dean NC, Dowell SF, File TM Jr, Musher DM, Niederman MS, Torres A, Whitney CG; Infectious Diseases Society of America; American Thoracic Society. Mandell LA, et al. Clin Infect Dis. 2007 Mar 1;44 Suppl 2(Suppl 2):S27-72. doi: 10.1086/511159. Clin Infect Dis. 2007. PMID: 17278083 Free PMC article. No abstract available.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical